{
  "first_published_at": "2008-01-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON084714", 
  "title": "Oral anticancer medicines: risk of incorrect dosing", 
  "tags": "{\"parsed_therapeutic\": [\"cancer\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Cancer\"]}", 
  "_document_number": 303, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/dose_icon.png", 
  "therapeutic_area": [
    "cancer"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Oral anticancer medicines: risk of incorrect dosing</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: January 2008</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!--The NPSA is alerting all healthcare professionals who use oral anticancer medicines about potentially fatal outcomes if incorrect doses are prescribed, dispensed, or administered. Risks are increased if healthcare practitioners who are not cancer specialists prescribe, dispense, or administer these medicines.-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>The <a href=\"http://www.npsa.nhs.uk/\" target=\"_blank\">National Patient Safety Agency</a> (NPSA) is alerting all healthcare professionals who use oral anticancer medicines about potentially fatal outcomes if incorrect doses are prescribed, dispensed, or administered. Risks are increased if healthcare practitioners who are not cancer specialists prescribe, dispense, or administer these medicines.</p><p>NPSA is issuing guidance to all clinical staff that the prescribing, dispensing, and administering of oral anticancer medicine should be carried out and monitored to the same standard as that for injected cancer therapy.</p><p>&nbsp;</p><p><em>Article citation: Drug Safety Update Jan 2008: Vol 1, Issue 6: 10</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>The <a href=\"http://www.npsa.nhs.uk/\" target=\"_blank\">National Patient Safety Agency</a> (NPSA) is alerting all healthcare professionals who use oral anticancer medicines about potentially fatal outcomes if incorrect doses are prescribed, dispensed, or administered. Risks are increased if healthcare practitioners who are not cancer specialists prescribe, dispense, or administer these medicines.</p><p>NPSA is issuing guidance to all clinical staff that the prescribing, dispensing, and administering of oral anticancer medicine should be carried out and monitored to the same standard as that for injected cancer therapy.</p><p>&#160;</p><p><em>Article citation: Drug Safety Update Jan 2008: Vol 1, Issue 6: 10</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2008-01-01", 
  "date_last_modified": "2010-08-11", 
  "_assets": [], 
  "_item_id": 303, 
  "summary": "", 
  "body": "Article date: January 2008\n\nThe [National Patient Safety Agency](http://www.npsa.nhs.uk/) (NPSA) is alerting all healthcare professionals who use oral anticancer medicines about potentially fatal outcomes if incorrect doses are prescribed, dispensed, or administered. Risks are increased if healthcare practitioners who are not cancer specialists prescribe, dispense, or administer these medicines.\n\nNPSA is issuing guidance to all clinical staff that the prescribing, dispensing, and administering of oral anticancer medicine should be carried out and monitored to the same standard as that for injected cancer therapy.\n\nÂ \n\nArticle citation: Drug Safety Update Jan 2008: Vol 1, Issue 6: 10\n"
}